Sponsor
José A. Luchsinger
Status
Terminated
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT03757910
This is a cross-sectional pilot study of Alzheimer's disease (AD) brain imaging biomarkers in Diabetes Prevention Program (DPP) outcomes study (DPPOS) participants from the New York City sites (Columbia and Einstein), comparing 10 persons originally randomized to metformin and 10 persons randomized to placebo in DPP. All study procedures will be conducted at Columbia University Irving Medical Center. Eligible participants will receive a PET scans and a brain MRI, which may be conducted in one, two, or three separate visits.
Intervention
11C-PIB, 18F-MK-6240
Condition
Alzheimer Disease
Investigators
Jose A. Luchsinger, MD